Earnings Summary

Novartis Ag’s revenue fell -10.02% since last year same period to $11776Mn in the Q4 2023. On a quarterly growth basis, Novartis Ag has generated -2.61% fall in its revenue since last 3-months.

Novartis Ag’s net profit jumped 478.44% since last year same period to $8480Mn in the Q4 2023. On a quarterly growth basis, Novartis Ag has generated 381.54% jump in its net profits since last 3-months.

Novartis Ag’s net profit margin jumped 542.84% since last year same period to 72.01% in the Q4 2023. On a quarterly growth basis, Novartis Ag has generated 394.47% jump in its net profit margins since last 3-months.

Novartis Ag’s earning per share (EPS) estimates for the current quarter stand at 1.67 - a -1.18% fall from last quarter’s estimates.

Novartis Ag’s earning per share (EPS) estimates for the current year stand at 1.67.

Novartis Ag’s earning per share (EPS) fell -100% since last year same period to 0 in the Q1 2024. This indicates that the Novartis Ag has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Novartis Ag declared 3.78 dividend per share during the earnings announcement for Q1 2024.